We have a new investigational research study evaluating the dose response of once-weekly injection in patients with Type 2 Diabetes between 18 and 64 years of age.

The total study participation is approximately 1 year.

If qualified, you may be compensated up to $1,110.00 for your time and travel. You will also receive study related care at no cost.

Qualified participants must:

  • Be a generally adult; 18-64 years of age
  • Have a BMI ≥0 kg/m2
  • Be diagnosed with Type 2 Diabetes
  • Have an HbA1c between 7.0-10.5%

Stay on track with clinical trials you can trust.

Get in touch with us today and subscribe to our newsletter to see how we can provide the clinical trial and scientific consulting services you need.